These glia–neuron interactions appear to be initiated shortly after FGF1 injection and may provide the structural and molecular framework for maintaining reduced AgRP neuron activity beyond the transient shift in transcriptional subpopulations, ultimately contributing to sustained diabetes remission (Fig. 5H). This evidence concerns the gene AGRP and diabetes mellitus.